Physician profile
Eric Peterson
NPI 1215598545
$1,642.34
in general payments reported to CMS, 2019-2025
15 companies · $383 in 2025
The $383 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $142 · 2023: $693 · 2024: $425 · 2025: $383.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,365 · Education: $135.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,365.20 |
| Education | $134.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $514.52 | 2022-2024 | Impella |
| Abbott Laboratories | $321.85 | 2023-2025 | Perclose Proglide, Ensite, Navitor |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $177.16 | 2024-2025 | Lifevest |
| Pfizer INC. | $143.80 | 2022-2025 | |
| Biosense Webster, INC. | $127.16 | 2025 | Carto 3, Qdot Micro |
| Boston Scientific Corporation | $112.07 | 2023 | Avvigo Guidance System |
| Altathera Pharmaceuticals LLC | $38.81 | 2023 | Sotalol Hydrochloride |
| Astrazeneca Pharmaceuticals Lp | $36.23 | 2024-2025 | Wainua, Farxiga |
| E.R. Squibb & Sons, L.L.C. | $30.16 | 2023 | Camzyos |
| Lexicon Pharmaceuticals, INC. | $29.83 | 2023 | Inpefa |
| Bayer Healthcare Pharmaceuticals INC. | $27.31 | 2023 | |
| Merck Sharp & Dohme LLC | $26.22 | 2022-2023 | Verquvo |
| Irhythm Technologies, INC. | $21.43 | 2023 | Zio Xt Patch |
| Glaxosmithkline, LLC. | $18.73 | 2025 | Shingrix, Arexvy |
| Impulse Dynamics (USA) INC. | $17.06 | 2024 | Optimizer |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Peterson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.